Treatment Options for Migraine Not Responding to NSAIDs, Antiemetics, and Triptans in Patients Under 40

Next-Line Treatment Options

The American College of Physicians recommends considering CGRP antagonists (gepants) including rimegepant, ubrogepant, or zavegepant for moderate to severe migraine headaches that don't respond to first-line treatments 1
Dihydroergotamine (DHE) has good evidence for efficacy and safety in treating refractory migraines, particularly in intranasal formulation 2
The American Academy of Neurology suggests that the ditan lasmiditan can be considered when patients don't respond to other pharmacologic treatments, though it should be reserved for cases where other options have failed 1, 3

The American College of Physicians recommends trying CGRP antagonists (gepants) such as rimegepant, ubrogepant, or zavegepant as the first alternative option 1
The American Academy of Neurology suggests considering dihydroergotamine (DHE), preferably in intranasal formulation, as the second alternative option 2
Lasmiditan is recommended for patients who don't tolerate or have inadequate response to all other treatments 1, 3

The American College of Physicians advises avoiding opioids and butalbital-containing medications for migraine treatment as they can lead to dependency, rebound headaches, and eventual loss of efficacy 1
The American Academy of Neurology warns of medication overuse headache, which can occur with frequent use of acute medications (≥15 days per month with NSAIDs; ≥10 days per month with triptans) 1, 3
The American Heart Association notes that DHE is contraindicated in patients with uncontrolled hypertension, coronary artery disease, or peripheral vascular disease 4

The American Academy of Neurology recommends considering preventive medications if episodic migraine occurs frequently or treatment doesn't provide adequate response 1, 3
The American Family Physician suggests that commonly accepted indications for migraine prevention include two or more migraine attacks per month with attacks producing disability for three or more days per month 4

The American College of Physicians emphasizes the importance of lifestyle modifications including staying well hydrated, maintaining regular meals, securing sufficient and consistent sleep, engaging in regular physical activity, managing stress, and identifying triggers 1, 3
The American Academy of Family Physicians recommends tracking progress with a daily headache diary to assess treatment response and identify triggers 4

The American College of Physicians suggests using a nonoral formulation (such as intranasal DHE) and an antiemetic for patients with severe nausea or vomiting 1
The American College of Obstetricians and Gynecologists recommends discussing the adverse effects of pharmacologic treatments during pregnancy and lactation with women of childbearing potential 1, 5